Cambridge Investment Research Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $167K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $152K | Buy |
|
|||||
|
2023
Q4 | $151K | Sell |
|
|||||
|
2023
Q3 | $254K | Buy |
|
|||||
|
2023
Q2 | $244K | Sell |
|
|||||
|
2023
Q1 | $262K | Buy |
|
|||||
|
2022
Q4 | $244K | Buy |
|
|||||
|
2022
Q3 | $195K | Sell |
|
|||||
|
2022
Q2 | $219K | Buy |
|
|||||
|
2022
Q1 | $200K | Sell |
|
|||||
|
2021
Q4 | $237K | Sell |
|
|||||
|
2021
Q3 | $316K | Sell |
|
|||||
|
2021
Q2 | $355K | Buy |
|
|||||
|
2021
Q1 | $375K | Buy |
|
|||||
|
2020
Q4 | $223K | Sell |
|
|||||
|
2020
Q3 | $232K | Buy |
|
|||||
|
2020
Q2 | $204K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $211K | Buy |
|